Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

ClinicalTrials.gov ID: NCT03886220

Public ClinicalTrials.gov record NCT03886220. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 5:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 4 Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main objective of this study is to assess safety and efficacy of elagolix compared to placebo in reducing heavy menstrual bleeding (HMB) associated with uterine fibroids in premenopausal women. The primary hypothesis is that elagolix, compared to placebo, reduces HMB associated with uterine fibroids in premenopausal women.

Study identification

NCT ID
NCT03886220
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
AbbVie
Industry
Enrollment
82 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 51 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 12, 2019 (Actual)
Primary completion
Mar 31, 2021 (Actual)
Completion
Apr 28, 2021 (Actual)
Last update posted
Mar 31, 2022

2019 – 2021

United States locations

U.S. sites
45
U.S. states
18
U.S. cities
38
Facility City State ZIP Site status
ACCEL Research Sites /ID# 209714 Birmingham Alabama 35218 —
University of Alabama at Birmingham - Women's and Infant's Center /ID# 209581 Birmingham Alabama 35294-7333 —
Unity Health- Searcy Medical Center /ID# 210905 Searcy Arkansas 72143-4802 —
Grossmont Ctr Clin Research /ID# 217690 La Mesa California 91942 —
Women's Health Care Research Corp /ID# 211472 San Diego California 92111-3738 —
Alliance for Multispecialty Research (AMR) - Fort Myers /ID# 213764 Fort Myers Florida 33912 —
Caceres Specialized Gynecology /ID# 214956 Kissimmee Florida 34741 —
LCC Medical Research Institute /ID# 213765 Miami Florida 33126 —
Genoma Research Group, Inc /ID# 213771 Miami Florida 33165 —
A Premier Medical Research of FL /ID# 214947 Orange City Florida 32763-2833 —
GCP Clinical Research, LLC /ID# 218742 Tampa Florida 33609-3588 —
Comprehensive Clinical Trials LLC /ID# 217177 West Palm Beach Florida 33409 —
Georgia Research for Women /ID# 211321 Atlanta Georgia 30312-1200 —
Atlanta Women's Research Institute /ID# 217745 Atlanta Georgia 30342 —
Medisense Inc /ID# 217750 Atlanta Georgia 30363 —
Women's Health of Augusta /ID# 214995 Augusta Georgia 30901-2775 —
Midtown OBGYN North /ID# 209391 Columbus Georgia 31909-5715 —
Journey Medical Research Institute - Snellville /ID# 217309 Snellville Georgia 30078-6191 —
Affinity Clinical Research /ID# 215252 Oak Brook Illinois 60523-1245 —
Clinical Trials Management, LLC - Covington /ID# 215020 Covington Louisiana 70433 —
Southern Clinical Research A /ID# 213732 Metairie Louisiana 70001 —
Johns Hopkins University /ID# 211135 Baltimore Maryland 21287 —
NECCR Fall River LLC /ID# 215009 Fall River Massachusetts 02720-2972 —
Excel Clinical Research /ID# 215936 Las Vegas Nevada 89109 —
Manhattan Medical Research /ID# 213753 New York New York 10016-6023 —
Upstate Clinical Research Associates /ID# 215156 Williamsville New York 14221-6046 —
M3 Wake Research Inc. /ID# 215166 Raleigh North Carolina 27612-8106 —
Carolina Medical Trials - Winston-Salem /ID# 215027 Winston-Salem North Carolina 27103-4109 —
Legacy Medical Group-Gynecologic Oncology /ID# 211016 Portland Oregon 97210-2900 —
Clinical Research of Philadelphia, LLC /ID# 213741 Philadelphia Pennsylvania 19114 —
Reading Hospital Clinical Trials Office /ID# 213763 West Reading Pennsylvania 19611 —
Clinical Trials of SC /ID# 210204 Charleston South Carolina 29406 —
Chattanooga Medical Research /ID# 215294 Chattanooga Tennessee 37404 —
WR-Medical Research Center of Memphis LLC /ID# 213756 Memphis Tennessee 38120-8328 —
Access Clinical Trials, Inc. /ID# 215357 Nashville Tennessee 37203 —
Signature Gyn Services /ID# 213883 Fort Worth Texas 76104 —
FMC Science, LLC - OB/GYN - Georgetown /ID# 211164 Georgetown Texas 78626-8185 —
University of Texas (UT) Health Women's Research Center at Memorial City /ID# 215193 Houston Texas 77024-2515 —
Advances in Health, Inc. /ID# 215847 Houston Texas 77030 —
Clinical Trials of Texas, Inc /ID# 213768 San Antonio Texas 78229 —
Discovery Clinical Trials-San Antonio /ID# 214996 San Antonio Texas 78258 —
Storks Research, LLC /ID# 211146 Sugar Land Texas 77479-1285 —
Houston Ctr for Clin Research /ID# 215138 Sugar Land Texas 77479 —
Seattle Clinical Research Center /ID# 210853 Seattle Washington 98105 —
North Spokane Women's Health /ID# 209889 Spokane Washington 99207 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03886220, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 31, 2022 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03886220 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →